Highlights and Quick Summary
- Research and Development (R&D) Expenses Growth for the quarter ending September 30, 2022 was -14.29% (a -396.47% decrease compared to previous quarter)
- Year-over-year quarterly Research and Development (R&D) Expenses Growth decreased by -144.94%
- Annual Research and Development (R&D) Expenses Growth for 2021 was 26.28% (a 96.56% increase from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2020 was 13.37% (a -80.43% decrease from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2019 was 68.32% (a 82.82% increase from previous year)
- Twelve month Research and Development (R&D) Expenses Growth ending September 30, 2022 was 3.12% (a -67.7% decrease compared to previous quarter)
- Twelve month trailing Research and Development (R&D) Expenses Growth decreased by -88.13% year-over-year
Trailing Research and Development (R&D) Expenses Growth for the last four month:
30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
---|---|---|---|
3.12% | 9.66% | 16.31% | 26.28% |
Visit stockrow.com/BCEL
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Research and Development (R&D) Expenses Growth of Atreca, Inc.
Most recent Research and Development (R&D) Expenses Growthof BCEL including historical data for past 10 years.Interactive Chart of Research and Development (R&D) Expenses Growth of Atreca, Inc.
Atreca, Inc. Research and Development (R&D) Expenses Growth for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | – | -14.29% | 4.82% | -7.2% | – |
2021 | 31.8% | 11.38% | 34.25% | 29.4% | 26.28% |
2020 | 17.98% | 31.19% | -10.94% | 21.32% | 13.37% |
2019 | 82.6% | 72.69% | 12.28% | -17.57% | 68.32% |
2018 | – | – | -45.23% | -42.09% | 37.37% |
2017 | – | – | – | – | -23.91% |
Business Profile of Atreca, Inc.
Sector: Healthcare
Industry: Biotechnology